Healthcare Draws $3.1 Billion as India PE/VC Deals Hit $17.1 Billion

By Olivia Hart, Business Bearings

Private equity and venture capital investment in India reached $17.1 billion across 348 deals in the third quarter of 2026, according to the EY-IVCA quarterly roundup. That is 46 percent more than the $11.7 billion invested in 3Q2025 and 124 percent more than the $7.6 billion recorded in 2Q2026. Healthcare drew $3.1 billion, second only to infrastructure, and the quarter's single largest transaction was a hospital buyout.

Deal count told a different story. The 348 transactions were 9 percent fewer than the 384 in 3Q2025, though 44 percent more than the 241 in 2Q2026. Fewer, larger cheques defined the quarter — but concentrated money is also more demanding money.

September was the strongest month of 2026 so far, with $7 billion invested. It was the highest monthly total since May 2024, when investment reached $7.3 billion.

What drove the large-deal wave?

The quarter recorded 36 large deals worth $13 billion — 97 percent more than the $6.6 billion across 26 large deals in 3Q2025, and 178 percent more than the $4.7 billion across 21 in 2Q2026. Large deals made up 76 percent of all PE/VC investment.

At the top sat KKR's acquisition of Medicover India for $1.4 billion. The sale values Medicover Hospitals India at an enterprise value of EUR 1.2 billion, with proceeds helping the Swedish parent push deeper into Poland, Germany, and Romania. Medicover India, set up in 2017, runs 24 hospitals with roughly 4,800 beds across South and West India. Notably, Medicover had been preparing the India business for an IPO before agreeing to the sale — a strategic pivot the roundup does not explain. The deal is expected to close in the fourth quarter of 2026.

The transaction extends an existing KKR platform. KKR took a controlling stake in Kerala's Baby Memorial Hospital in 2024, holds 54 percent of cancer care chain HealthCare Global, and with Medicover added, its bed count in southern India nears 10,000. Baby Memorial has also agreed to take a controlling stake in Hyderabad-based Star Hospitals.

Advent International paid INR 3,150 crore for close to a quarter of Yatharth Hospitals on September 17, at about 33 times EBITDA against an average of 27 times for listed chains. Hospital systems attracted $1.8 billion in the quarter, the largest share of PE flowing into Indian healthcare.

Why does hospital consolidation matter to suppliers?

Blackstone, KKR, TPG, General Atlantic, and other global investors have spent about $10 billion on stakes in Indian hospital chains over the past five years, according to EY data. Private hospitals already handled 60.3 percent of hospitalisation cases in the NSS 80th Round data, against 36.7 percent for government hospitals.

At current entry valuations, returns depend on post-closing execution: further acquisitions, higher revenue per occupied bed, centralized procurement, finance and IT, and a shift toward oncology, cardiac sciences, and transplants. For vendors, that typically means group-level rate contracts, fewer and larger tenders, and tighter scrutiny of total cost of ownership. Aster DM Healthcare announced an INR 6,900 crore expansion plan on September 18.

How did deal types and sectors split?

• Buyouts: $5.1 billion, up 419 percent from $1 billion in 3Q2025; Medicover alone was over a quarter of that value.
• Start-ups: $4.8 billion, up 55 percent from $3.1 billion.
• Growth: $3.5 billion, down 2 percent.
• PIPEs: $2.6 billion, up from $1.5 billion.
• Credit: $1.2 billion, down 54 percent from $2.6 billion.

Pure-play PE/VC investment stood at $8.5 billion, 2 percent lower year on year; real estate and infrastructure jumped 182 percent to $8.6 billion. Infrastructure led sectors at $7.2 billion, healthcare followed at $3.1 billion, real estate at $1.4 billion — together 69 percent of the total. Broader healthcare M&A, including pharma, logged 87 transactions worth $4.3 billion.

What happened on exits and IPOs?

Exits totaled $10.4 billion across 113 deals, the highest quarterly value in the trailing 12 months — though 24 percent below the $13.7 billion of 3Q2025. Open market exits led with $5.9 billion across 54 deals. The quarter saw 27 PE-backed IPOs, the most in any single quarter, but their exit value fell to $1.2 billion from $8.6 billion a year earlier. Volume without value is a caveat worth holding. The largest exit was Avaada Ventures' $701 million debt repayment to Brookfield Renewable.

Since 2016, India has seen 290 PE/VC-backed IPOs; 217 since 2021 returned $17.1 billion to investors. EY expects IPO success to depend increasingly on profitability and earnings visibility rather than market momentum, with mid-cap multiples compressing. For hospital assets priced well above listed peers, that places procurement efficiency and bed utilization at the center of exit value.

Fundraising totaled $6.4 billion across 32 funds, down from $16.2 billion in 3Q2025. The largest was NIIF Infrastructure Fund II's $2 billion first close. With the RBI hiking the repo rate amid high crude prices, EY expects investors to stay cautious — yet large, scaled hospital platforms have so far met the test, keeping healthcare delivery near the top of the private capital agenda heading into 2027.